| commit | a229bed69fd0727ae395efe7bb6d186402fc23a6 | [log] [tgz] |
|---|---|---|
| author | leba <leba@google.com> | Mon Mar 28 01:02:20 2022 -0700 |
| committer | Copybara-Service <copybara-worker@google.com> | Mon Mar 28 01:03:39 2022 -0700 |
| tree | 62ceb76b28126d84141ef4f7299bb8bcc5addac2 | |
| parent | 29686447b79085389c9212553e4ea697ca2fd550 [diff] |
Improve action conflict checker's performance with Skymeld. We identified 2 big performance pain points: - The traversal to collect transitive ActionLookupKeys before each conflict check, and - The processed ActionLookupKeys are repeatedly re-visited by the IncrementalArtifactConflictChecker. This CL fixes the above problems by introducing various caches to prevent re-visitation of the ActionLookupKeys. PiperOrigin-RevId: 437689002
{Fast, Correct} - Choose two
Build and test software of any size, quickly and reliably.
Speed up your builds and tests: Bazel rebuilds only what is necessary. With advanced local and distributed caching, optimized dependency analysis and parallel execution, you get fast and incremental builds.
One tool, multiple languages: Build and test Java, C++, Android, iOS, Go, and a wide variety of other language platforms. Bazel runs on Windows, macOS, and Linux.
Scalable: Bazel helps you scale your organization, codebase, and continuous integration solution. It handles codebases of any size, in multiple repositories or a huge monorepo.
Extensible to your needs: Easily add support for new languages and platforms with Bazel's familiar extension language. Share and re-use language rules written by the growing Bazel community.
Follow our tutorials:
To report a security issue, please email security@bazel.build with a description of the issue, the steps you took to create the issue, affected versions, and, if known, mitigations for the issue. Our vulnerability management team will respond within 3 working days of your email. If the issue is confirmed as a vulnerability, we will open a Security Advisory. This project follows a 90 day disclosure timeline.
See CONTRIBUTING.md
